Abstract
We describe herein tetrapeptidyl α-ketoamide 4A based systematic P1 modifications alone or/and in combination with further P1; variations. These SAR efforts led to the discovery of a number of potent and selective HCV NS3 protease inhibitors such as 4B, 9, and 12 endowed with impressive cellular activity as measured in the replicon assay and very good therapeutic indexes. On the basis of its overall profile, compound 4B (VX-950) has been selected for human clinical trials.
Keywords: hcv infection, ns3 protease, enzyme inhibition, replicon assay, cytotoxicity, alpha-ketoamide
Letters in Drug Design & Discovery
Title: P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors
Volume: 2 Issue: 2
Author(s): Shu-Hui Chen, Jason Lamar, Yvonne Yip, Frantz Victor, Robert B. Johnson, Q. May Wang, John I. Glass, Beverly Heinz, Joseph Colacino, Deqi Guo, Mark Tebbe and John E. Munroe
Affiliation:
Keywords: hcv infection, ns3 protease, enzyme inhibition, replicon assay, cytotoxicity, alpha-ketoamide
Abstract: We describe herein tetrapeptidyl α-ketoamide 4A based systematic P1 modifications alone or/and in combination with further P1; variations. These SAR efforts led to the discovery of a number of potent and selective HCV NS3 protease inhibitors such as 4B, 9, and 12 endowed with impressive cellular activity as measured in the replicon assay and very good therapeutic indexes. On the basis of its overall profile, compound 4B (VX-950) has been selected for human clinical trials.
Export Options
About this article
Cite this article as:
Chen Shu-Hui, Lamar Jason, Yip Yvonne, Victor Frantz, Johnson B. Robert, Wang May Q., Glass I. John, Heinz Beverly, Colacino Joseph, Guo Deqi, Tebbe Mark and Munroe E. John, P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors, Letters in Drug Design & Discovery 2005; 2 (2) . https://dx.doi.org/10.2174/1570180053175115
DOI https://dx.doi.org/10.2174/1570180053175115 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mental Disorders and Poor COVID-19 Prognosis: Reevaluating the Relationship
through Ca<sup>2+</sup>/cAMP Signalling
Current Topics in Medicinal Chemistry Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis, and Investigational Therapeutics
Current Medicinal Chemistry <i>Chemi-Informatic</i> Approach to Investigate Putative Pharmacoactive Agents of Plant Origin to Eradicate COVID-19
Coronaviruses Design, Synthesis and Antimicrobial Activity of α-Aminophosphonates of Quinoline and their Molecular Docking Studies Against DNA Gyrase A
Letters in Drug Design & Discovery Alogliptin: a Novel Molecule for Improving Glycemic Control in Type II Diabetes Mellitus
Current Diabetes Reviews Design, Synthesis and Biological Evaluation of 5-Amino-1H-pyrazole-4- carboxamide Derivatives as Potential Antitumor Agents
Letters in Drug Design & Discovery Cell Counter can be Interfered by Mobile Phone Radiofrequency Radiation: A Report and Short Review of the Recent Patents in Electromagnetic Interference
Recent Patents on Biomarkers Therapeutic Potential of the Modulation of Sphingosine-1-Phosphate Receptors
Current Medicinal Chemistry Exploring the Multitarget Potential of Iridoids: Advances and Applications
Current Topics in Medicinal Chemistry Covid-19 Vaccines Available in India
Combinatorial Chemistry & High Throughput Screening The Main Receptors Involved in the COVID-19: A Systematic Review and Meta-Analysis
Current Medicinal Chemistry Recent Advances on Platensimycin: A Potential Antimicrobial Agent
Current Medicinal Chemistry Thymosin α1; Potential Therapeutic Implications of an Immunoregulatory Drug in the Treatment of Lymphocytopenia Associated with COVID-19
Current Immunology Reviews (Discontinued) Potential Papain-like Protease Inhibitors Against COVID-19: A Comprehensive <i>In Silico</i> Based Review
Combinatorial Chemistry & High Throughput Screening Some Flavolignans as Potent Sars-Cov-2 Inhibitors <i>via</i> Molecular Docking, Molecular Dynamic Simulations and ADME Analysis
Current Computer-Aided Drug Design Dopamine D5 Receptors: A Challenge to Medicinal Chemists
Mini-Reviews in Medicinal Chemistry The Preliminary Identification of Potential Vaccine Targets for SARSCoV2 and Computer-aided Synthesis ("Small Interfering RNA Design")
Current Enzyme Inhibition Trends in Deep Learning for Property-driven Drug Design
Current Medicinal Chemistry Biologically Active Selenophenes and Benzo[b]selenophenes
Current Organic Synthesis Antimalarial Activity of 2,4-Diaminopyrimidines
Letters in Drug Design & Discovery